Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 251.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,875 shares of the medical instruments supplier’s stock after purchasing an additional 7,782 […]
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect LeMaitre Vascular to post earnings of $0.39 per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. LeMaitre Vascular (NASDAQ:LMAT […]
Linden Thomas Advisory Services LLC grew its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 2.9% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 29,996 shares of the medical instruments supplier’s stock after buying an additional 839 shares during the […]
LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) and PolyPid (NASDAQ:PYPD – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Valuation & Earnings This table compares LeMaitre Vascular […]